Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 7 Recurrence 5 Glioblastoma 4 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Neoplasms, Plasma Cell 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioma 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thymoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Richter's Transformation 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1

Interventions

Prednisone 101 Docetaxel 79 Leuprolide 72 Abiraterone Acetate 62 enzalutamide 59 bicalutamide 44 Goserelin 44 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 38 Radiotherapy 33 gallium 68 PSMA-11 21 apalutamide 21 abiraterone 21 Magnetic Resonance Spectroscopy 21 Gonadotropin-Releasing Hormone 21 luprolide acetate gel depot 19 sipuleucel-T 18 Androgen Antagonists 18 Triptorelin Pamoate 17 Radiosurgery 17 cabazitaxel 15 Radiotherapy, Intensity-Modulated 14 pembrolizumab 13 cabozantinib 13 Prednisolone 12 Flutamide 12 Dexamethasone 12 Brachytherapy 12 radium Ra 223 dichloride 11 fluciclovine F-18 11 Radiation 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02146833 2023-01-26

SHIP

Karyopharm Therapeutics Inc

Phase 2 Terminated

20 enrolled 13 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡